APSA Pediatric Surgery Library combines Pediatric Surgery Not a Textbook (NaT) with APSA ExPERT, a powerful platform for earning MOC CME credits -- all powered by Unbound Medicine. Explore these free sample topics:
-- The first section of this topic is shown below --
The management of portal hypertension in children is becoming increasingly more focused on correcting the underlying cause of the condition and curing the underlying problem whenever possible. The pediatric surgeon, when confronted with a child who has portal hypertension, must be able to properly advise the family of the child on the appropriate course of therapy. The pediatric surgeon may not infrequently be called in consult to a child with hematemesis or the passage of frank blood or melena in the stool. Alternately, the surgeon may be called upon to see a child with a large spleen, distended abdominal veins or ascites. It is important that the surgeon be familiar with the symptoms and the physical signs of portal hypertension, be able to order appropriate ancillary testing and ultimately participate in a meaningful manner in the management and disposition of the child with portal hypertension.
The most critical aspects of portal hypertension are
The most challenging areas are the early recognition of the signs and symptoms of portal hypertension and to have the ability to discriminate among the causes of portal hypertension that are amenable to surgical correction, those that are best managed medically and those that may require referral to a transplant center for those children whose portal hypertension is a manifestation of end stage liver disease. Most children with portal hypertension should be referred to a center with the multidisciplinary capabilities to adequately deliver the complex care that these children often need.
The operative strategies involved in the correction of portal vein thrombosis are likely to change with regard to the venous grafts that are often necessary for the reconstruction of portal venous blood toward the liver. Work is being done with tissue engineering that may obviate the need for the procurement of autologous vein grafts.
Content in this topic is referenced in SCORE Portal Hypertension overview